Literature DB >> 12890211

Circulating natural killer cells in psoriasis.

A L Cameron1, B Kirby, C E M Griffiths.   

Abstract

BACKGROUND: Psoriasis is an immunologically mediated, probably autoimmune, disease in which T-helper type 1 cytokines play an important role. Established autoimmune diseases, with similar mechanistic characteristics to psoriasis, include multiple sclerosis, rheumatoid arthritis, type 1 diabetes mellitus and systemic lupus erythematosus. Natural killer (NK) and natural killer-T (NK-T) cells are considered key to the pathogenesis of these conditions, which are characterized by reduced numbers of NK cells in peripheral blood. NK and NK-T cells have been implicated in the pathogenesis of psoriasis and are present in plaques of psoriasis.
OBJECTIVES: To investigate whether levels of NK and NK-T cells are reduced in the peripheral blood of patients with psoriasis.
METHODS: Fourteen patients with untreated psoriasis, mean +/- SD age 46 +/- 13 years, and 13 healthy volunteers, mean +/- SD age 34 +/- 9 years, were venesected and peripheral blood mononuclear cells isolated, labelled with a panel of antibodies to T-cells and NK cells including CD3, CD56, CD57, CD16, CD94, CD158a, CD69 and cutaneous lymphocyte-associated antigen (CLA) and analysed using triple-colour flow cytometry.
RESULTS: There were significantly fewer cells expressing the NK-cell markers CD16 (P < 0.001), CD56 (P < 0.003), CD94 (P < 0.001) and CD158a (P < 0.02) in patients with psoriasis compared with normal controls. However, circulating numbers of NK-T cells (CD3+ CD56+ CD57+), T-cells (CD3+), activated lymphocytes (CD69+) or CLA+ cells were not significantly different between patients with psoriasis and controls.
CONCLUSIONS: Circulating NK cells are reduced in psoriasis. This finding is similar to those in established autoimmune diseases such as rheumatoid arthritis. This observation provides some evidence that psoriasis may be an autoimmune disease in which NK cells play a role.

Entities:  

Mesh:

Year:  2003        PMID: 12890211     DOI: 10.1046/j.1365-2133.2003.05319.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  25 in total

1.  Analysis of granulysin-mediated cytotoxicity in peripheral blood of patients with psoriatic arthritis.

Authors:  Drazen Massari; Larisa Prpic-Massari; Tatjana Kehler; Marija Kastelan; Bozidar Curkovic; Viktor Persic; Alen Ruzic; Gordana Laskarin
Journal:  Rheumatol Int       Date:  2011-08-10       Impact factor: 2.631

2.  Scleritis and multiple systemic autoimmune manifestations in chronic natural killer cell lymphocytosis associated with elevated TCRalpha/beta+CD3+CD4-CD8- double-negative T cells.

Authors:  S Yeh; Z Li; H N Sen; W-K Lim; F Gill; K Perkins; V K Rao; R B Nussenblatt
Journal:  Br J Ophthalmol       Date:  2010-06       Impact factor: 4.638

3.  Skewed distribution of natural killer cells in psoriasis skin lesions.

Authors:  Mariana D Batista; Emily L Ho; Peter J Kuebler; Jeffrey M Milush; Lewis L Lanier; Esper G Kallas; Vanessa A York; David Chang; Wilson Liao; Patrick Unemori; Kieron S Leslie; Toby Maurer; Douglas F Nixon
Journal:  Exp Dermatol       Date:  2013-01       Impact factor: 3.960

4.  IL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models.

Authors:  Young-Eun Park; Geun-Tae Kim; Seung-Geun Lee; Seong-Hu Park; Seung-Hoon Baek; Sung-Il Kim; Ju-In Kim; Hua-Shu Jin
Journal:  Rheumatol Int       Date:  2012-04-19       Impact factor: 2.631

Review 5.  The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy.

Authors:  Chris Fraker; Allison L Bayer
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 6.  Psoriasis: advances in pathophysiology and management.

Authors:  A MacDonald; A D Burden
Journal:  Postgrad Med J       Date:  2007-11       Impact factor: 2.401

7.  A comparative analysis of in vitro expansion of natural killer cells of a patient with autoimmune haemolytic anaemia and ovarian cancer with patients with other solid tumours.

Authors:  Vidyasagar Devaprasad Dedeepiya; Hiroshi Terunuma; Xuewen Deng; Subramani Baskar; Sadananda Rao Manjunath; Rajappa Senthilkumar; Palanisamy Murugan; Paramasivam Thamaraikannan; Thangavelu Srinivasan; Senthilkumar Preethy; Samuel J K Abraham
Journal:  Oncol Lett       Date:  2011-11-29       Impact factor: 2.967

Review 8.  Cross-Disease Transcriptomics: Unique IL-17A Signaling in Psoriasis Lesions and an Autoimmune PBMC Signature.

Authors:  William R Swindell; Mrinal K Sarkar; Yun Liang; Xianying Xing; Johann E Gudjonsson
Journal:  J Invest Dermatol       Date:  2016-05-17       Impact factor: 8.551

9.  Paradoxes in dermatology.

Authors:  Keshavmurthy A Adya; Arun C Inamadar; Aparna Palit
Journal:  Indian Dermatol Online J       Date:  2013-04

10.  Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis.

Authors:  A E Hogan; A M Tobin; T Ahern; M A Corrigan; G Gaoatswe; R Jackson; V O'Reilly; L Lynch; D G Doherty; P N Moynagh; B Kirby; J O'Connell; D O'Shea
Journal:  Diabetologia       Date:  2011-07-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.